Butyraldehyde
Title: Butyraldehyde
CAS Registry Number: 123-72-8
CAS Name: Butanal
Molecular Formula: C4H8O
Molecular Weight: 72.11
Percent Composition: C 66.62%, H 11.18%, O 22.19%
Line Formula: CH3CH2CH2CHO
Literature References: Prepn from butyryl chloride: Brown, Tsukamoto, J. Am. Chem. Soc. 83, 2016 (1961); by reduction of corresponding nitrile: Gaiffe, Pallaud, Compt. Rend. 254, 496 (1962); by alkali aluminum hydride reduction of methyl butyrate: Zakharkin et al., Tetrahedron Lett. 1963, 208; by oxidation of butanol: Harrison, Proc. Chem. Soc. London 1964, 110. Usually manuf by catalytic dehydrogenation of butanol, catalytic hydrogenation of crotonaldehyde, or by the oxo process from propene, e.g., see: Dunbar, Arnold, J. Org. Chem. 10, 501 (1945); Horn, Ind. Eng. Chem. 51, 655 (1959); W. L. Faith et al., Industrial Chemicals (John Wiley, New York, 3rd ed., 1965) pp 183, 304-305. Toxicity study: Smyth et al., Arch. Ind. Hyg. Occup. Med. 4, 119 (1951). Review: P. D. Sherman in Kirk-Othmer Encyclopedia of Chemical Technology vol. 4 (Wiley-Interscience, New York, 3rd ed., 1978) pp 376-386.
Properties: Flammable liquid. bp 74.8°. mp -99°. Closed-cup flash pt -6.67°C (20°F). d420 0.8016. nD20 1.379. Soly in water at 25°, 7.1 (wt-%): Smith, Bonner, Ind. Eng. Chem. 43, 1169 (1951). Miscible with ethanol, ether, ethyl acetate, acetone, toluene, many other organic solvents and oils. Single-dose LD50 orally in rats: 5.89 g/kg (Smyth).
Melting point: mp -99°
Boiling point: bp 74.8°
Flash point: flash pt -6.67°C (20°F)
Index of refraction: nD20 1.379
Density: d420 0.8016
Toxicity data: Single-dose LD50 orally in rats: 5.89 g/kg (Smyth)
CAUTION: May act as irritant, narcotic.
Use: Chiefly in the manuf of rubber accelerators, synthetic resins, solvents, plasticizers.

Others monographs:
Dicyanodiamidine SulfateZinc ValerateCaspase-8Crotonaldehyde
SulfamethizoleOil of Wine, “Heavy”PseudoaconitineAprepitant
1-OctanolChorismic AcidDecamethylcyclopentasiloxaneBacampicillin
α-SpinasterolCefpodoxime ProxetilGentian VioletAliskiren
©2016 DrugLead US FDA&EMEA